BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6195037)

  • 21. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
    Wong F; Logan A; Blendis L
    Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resuscitation from hemorrhagic shock: experimental model comparing normal saline, dextran, and hypertonic saline solutions.
    Chiara O; Pelosi P; Brazzi L; Bottino N; Taccone P; Cimbanassi S; Segala M; Gattinoni L; Scalea T
    Crit Care Med; 2003 Jul; 31(7):1915-22. PubMed ID: 12847383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis.
    Baruch Y; Assy N; Weisbruch F; Reisner SA; Rinkevich D; Enat R; Blendis LM; Bomzon A
    Am J Gastroenterol; 1999 Oct; 94(10):3000-4. PubMed ID: 10520859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.
    Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP
    Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
    Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
    Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
    Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
    Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function.
    Tuininga YS; Crijns HJ; Oosterhuis B; Wiesfeld AC; van Wijk LM; Albronda F; de Bruin H; Jonkman JH; Kozma C; Lie KI
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):408-14. PubMed ID: 7515984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chronic and progressive increase of portal venous pressure on renal handling of water and electrolytes in rats.
    Blanchart A; Fernández-Muñoz D; Caramelo C; Hernando L; López-Novoa JM
    Miner Electrolyte Metab; 1985; 11(5):295-300. PubMed ID: 3900673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.
    Wong F; Liu P; Lilly L; Bomzon A; Blendis L
    Clin Sci (Lond); 1999 Sep; 97(3):259-67. PubMed ID: 10464050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites.
    Stanley AJ; Forrest EH; Dabos K; Bouchier IA; Hayes PC
    Gastroenterology; 1998 Aug; 115(2):406-11. PubMed ID: 9679046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension.
    Belfort MA; Anthony J; Buccimazza A; Davey DA
    Obstet Gynecol; 1990 Jun; 75(6):970-4. PubMed ID: 1692982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis.
    Laffi G; Barletta G; La Villa G; Del Bene R; Riccardi D; Ticali P; Melani L; Fantini F; Gentilini P
    Gastroenterology; 1997 Sep; 113(3):891-8. PubMed ID: 9287981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis.
    Fernández-Rodriguez CM; Prieto J; Zozaya JM; Quiroga J; Guitián R
    Gastroenterology; 1993 Apr; 104(4):1139-45. PubMed ID: 8462804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
    Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA
    Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial natriuretic peptide and hemodynamic changes after concentrated ascitic fluid reinfusion in cirrhotic patients.
    Messa P; Cannella G; Mioni G; Boscutti G; Messa M; De Biasi F; Cioni A
    Nephron; 1993; 65(1):67-72. PubMed ID: 8413794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.